Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1CNS 1Breast 1

Conditions

Unipolar Major Depression 1

Interventions

Cyclophosphamide 424Trastuzumab 415Paclitaxel 376Docetaxel 314Capecitabine 266Letrozole 262Carboplatin 257Doxorubicin 213Tamoxifen 184Fulvestrant 176Epirubicin 176Radiotherapy 171Anastrozole 164pembrolizumab 152pertuzumab 147Surveys and Questionnaires 146Exercise 142exemestane 128Vinorelbine 127palbociclib 124Bevacizumab 123Magnetic Resonance Spectroscopy 120Blood Specimen Collection 120Drug Therapy 106Albumin-Bound Paclitaxel 105Gemcitabine 99130-nm albumin-bound paclitaxel 98pyrotinib 92eribulin 90Biopsy 88

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Vortioxetine × Breast × Clear all
NCT02637466 2016-09-30

Vortioxetine for MDD, Cognition, and Systemic Inflammatory Biomarkers

University of Miami

Phase 4 Withdrawn
Breast

Unipolar Major Depression

Data powered by HemOnc (CC BY 4.0) Colophon âš¡